Delusion

A phase 2 clinical trial has been initiated to evaluate the safety and efficacy of an inverse agonist for hallucinations and delusions associated with Alzheimer’s disease psychosis, according to the manufacturer.

False memories are not associated with delusions in patients with Alzheimer’s disease, according to a study published in JAMA Psychiatry.

A theoretically driven cognitive therapy program significantly reduced persistent persecutory delusions compared with a befriending intervention among patients with non-affective psychosis.